PJP

Invesco Dynamic Pharmaceuticals ETF [PJP] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

PJP Stock Summary

Top 10 Correlated ETFs

PJP

Top 10 Correlated Stocks

PJP

In the News

PJP Financial details

Company Rating
-
Market Cap
481.38M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.77
Dividend %
1%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
0.01
Current Ratio
1
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-339.77%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-6.55%
Revenue last 5Y
-10.96%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
9.42%
SMA50
14.27%
SMA100
27.93%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
67.75-80.65
52W High
+31.76%
52W Low
+57.33%
RSI
66.58
Rel Volume
0.35
Avg Volume
29.23K
Volume
10.13K
Perf Week
1.27%
Perf Month
10.81%
Perf Quarter
28.3%
Perf Half Y
31.17%
-
-
-
-
Beta
0.52
-
-
Volatility
0.91%, 4.14%
Prev Close
1.41%
Price
105.409
Change
0.52%

PJP Financial Performance

PJP Dividend History

PJP Frequently Asked Questions

What is Invesco Dynamic Pharmaceuticals ETF stock symbol ?

Invesco Dynamic Pharmaceuticals ETF is a US stock and trading under the symbol PJP

What is Invesco Dynamic Pharmaceuticals ETF stock quote today ?

Invesco Dynamic Pharmaceuticals ETF stock price is $105.409 today.

Is Invesco Dynamic Pharmaceuticals ETF stock public?

Yes, Invesco Dynamic Pharmaceuticals ETF is a publicly traded company.

Something similar

Top by Market Cap
AMZN
TL0.DE
1YD.DE
LLY.DE
CMC.DE
Top Correlated ETFs
BBH
FTXH
IHE
PPH
IBBQ
Top Correlated Stocks
BKD
TBPH
SHSCX
SHSKX
SHSSX
Similar Market Cap
AAD.DE
SWEF.L
VERT-B.ST
0343.HK
RMR

Company Profile

Financial Services Asset Management
  • Volume Average 29.23K
  • Market Capitalization 481.38M
  • Headquarters US
  • IPO Date 2005-06-23

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.